Topgenebio is able to develop personalized carcinogenicity study protocols for clients based on factors such as the drug's mechanism of action, treatment duration, exposure levels, and previous toxicology data. The company has a professional team of toxicologic pathologists with extensive experience in background data from carcinogenicity studies and the diagnosis of neoplastic lesions, enabling a comprehensive interpretation of the study results.